Actatecan

Product TA

Antineoplastic

Active Ingredient

Irinotecan

Route Of Administration

IV

Product type

Specialty


Product Details

Specialty

Oncology

Strength

100 mg

Product Form

Vial

Registration Number

DKI1429200249A1

Consumer Information Leaflet


Product Details

Specialty

Oncology

Strength

40 mg

Product Form

Vial

Registration Number

Consumer Information Leaflet


Additional products

Gemtavis

Product TA

Antineoplastic

Active Ingredient

Gemcitabine

Route Of Administration

IV

Product type

Specialty
View Product

Oncotaxel

Product TA

Antineoplastic

Active Ingredient

Docetaxel

Route Of Administration

IV

Product type

Specialty
View Product

Page Last Updated: 30 August 2021